In accordance with these, Lee et al. [8] observed that the expression of SREBP-2 and cholesterol metabolism genes such as HMG-CoA reductase and LDL receptor appear to be decreased in ccRCC patients. The gene discussed is SREBF2; the disease is nonpapillary renal cell carcinoma.